Independent Advisor Alliance’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Sell |
7,707
-241
| -3% | -$11.7K | 0.01% | 668 |
|
|
2025
Q1 | $270K | Buy |
7,948
+167
| +2% | +$5.68K | 0.01% | 685 |
|
|
2024
Q4 | $306K | Buy |
7,781
+62
| +0.8% | +$2.44K | ﹤0.01% | 1133 |
|
|
2024
Q3 | $363K | Buy |
7,719
+1,745
| +29% | +$82K | 0.01% | 524 |
|
|
2024
Q2 | $323K | Buy |
5,974
+80
| +1% | +$4.32K | 0.01% | 555 |
|
|
2024
Q1 | $402K | Buy |
5,894
+532
| +10% | +$36.3K | 0.01% | 500 |
|
|
2023
Q4 | $336K | Sell |
5,362
-9,894
| -65% | -$619K | 0.01% | 523 |
|
|
2023
Q3 | $692K | Buy |
15,256
+11,685
| +327% | +$530K | 0.03% | 353 |
|
|
2023
Q2 | $200K | Buy |
+3,571
| New | +$200K | 0.01% | 625 |
|
|
2022
Q2 | – | Sell |
-3,842
| Closed | -$241K | – | 640 |
|
|
2022
Q1 | $241K | Buy |
3,842
+1,011
| +36% | +$63.4K | 0.01% | 555 |
|
|
2021
Q4 | $215K | Buy |
+2,831
| New | +$215K | 0.01% | 613 |
|